 | • レポートコード：PMR201222 • 出版社/出版日：Persistence Market Research / 2020年10月15日 • レポート形態：英文、PDF、193ページ • 納品方法：Eメール • 産業分類：生命科学 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは漢方薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、主要成功要因、需要分析・予測、製品別（TCM、非TCM）分析、疾患別（ASD、ADHD）分析、地域別分析、主要・新興国分析、市場構造分析、競争分析、仮定、調査手法などの項目を掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景 ・主要成功要因 ・需要分析・予測 ・漢方薬の世界市場規模：製品別（TCM、非TCM） ・漢方薬の世界市場規模：疾患別（ASD、ADHD） ・漢方薬の世界市場規模：地域別 ・主要・新興国分析 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Traditional Chinese Medicine Market – Scope of the Report
A latest publication by Persistence Market Research (PMR) on the global traditional Chinese medicine market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global traditional Chinese medicine market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the traditional Chinese medicine market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.
Important indicators for the successful growth of the traditional Chinese medicine market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR). This research study can support readers to know the demand for traditional Chinese medicines and quantitative development opportunities during the study period.
The research is beneficial for shareholders in the traditional Chinese medicine industry, including market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the traditional Chinese medicine market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the traditional Chinese medicine market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the traditional Chinese medicine market are also included in the current study. Depending on potential developments in the traditional Chinese medicine market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this traditional Chinese medicine market report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the traditional Chinese medicine market.
Key Questions Answered in PMR’s Traditional Chinese Medicine Market Report
Which regions will continue to remain the most profitable regional markets for traditional Chinese medicine market players?
Which factors will induce a change in the demand for traditional Chinese medicines during the assessment period?
How will changing trends impact the traditional Chinese medicine market?
How can market players capture the low-hanging opportunities in the traditional Chinese medicine market in developed regions?
What are the winning strategies of stakeholders in the traditional Chinese medicine market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and might tackle while investing in the traditional Chinese medicine market?
What are the developmental trends in traditional Chinese medicine sectors that will impact the market?
How can businesses in the traditional Chinese medicine market avail the growth opportunities in developed and emerging sectors?
Traditional Chinese Medicine Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the traditional Chinese medicine market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the traditional Chinese medicine market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the traditional Chinese medicine market, and makes PMR’s projections on the growth prospects of the market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Global Traditional Chinese Medicine Market: Taxonomy
2.2. Traditional Chinese Medicine Market- Definition
3. Key Market Trends
3.1. Global Traditional Chinese Medicine Market- Trends
3.2. Detailed COVID19 Impact Analysis
3.2.1. Current COVID19 Statistics
3.2.2. COVID19 impact on GDP and measures
3.2.3. Epidemiology Forecast and Recovery Scenario
4. Market Background
4.1. Worldwide ASD and ADHD Epidemiology
4.2. Global TCM & Non-TCM Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity Analysis
4.3. Global ADHD and ASD Therapeutics Market: Supply-side Drivers
4.4. Global ADHD and ASD Therapeutics Market – Demand Side Drivers
4.5. Global ADHD and ASD Therapeutics Market – Drivers
4.6. Global ADHD and ASD Market – Demand Side Drivers
4.7. Global ADHD and ASD Market Dynamics – Restraints
4.8. Global ADHD and ASD Therapeutics Market Dynamics – Opportunities
5. Key Success Factors
5.1. Macroeconomic Factors: Global GDP Outlook
5.2. Macroeconomic Factors: Pharmaceutical Industry Demand Outlook
5.3. Macroeconomic Factors: Global Pharmaceutical R&D Spend
5.4. Forecast Factors: Relevance and Impact
5.5. Traditional Chinese Medicine Market – Key Promotional Strategies
5.6. ASD and ADHD Therapy Value Chain
5.7. Porter’s Five Forces Analysis
6. Global Traditional Chinese Medicine Market Demand (in Value or Size in US$ Mn) Analysis 2015–2019 and Forecast, 2020–2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Opportunity Analysis, 2020 – 2030
7. Global Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030, By Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product Type , 2015 – 2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020 – 2030
7.3.1. TCM
7.3.2. Non-TCM
7.4. Market Attractiveness Analysis By Product Type
8. Global Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030, By Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015 – 2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020 – 2030
8.3.1. ASD
8.3.2. ADHD
8.4. Market Attractiveness Analysis By Indication
9. Global Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030, by Region
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia
9.3.6. Oceania
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Product Type
10.3.3. By Indication
10.4. Market Attractiveness Analysis
10.5. Key Market Participants – Intensity Mapping
10.6. Drivers and Restraints – Impact Analysis
11. Latin America Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Rest of Latin America
11.3.1. By Product Type
11.3.2. By Indication
11.4. Market Attractiveness Analysis
11.5. Key Market Participants – Intensity Mapping
11.6. Drivers and Restraints – Impact Analysis
12. Europe Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. U.K.
12.3.1.3. France
12.3.1.4. Italy
12.3.1.5. Spain
12.3.1.6. Benelux
12.3.1.7. Russia
12.3.1. By Product Type
12.3.2. By Indication
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. East Asia Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. China
13.3.1.2. South Korea
13.3.1.3. Japan
13.3.1. By Product Type
13.3.2. Indication
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. South Asia Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. India
14.3.1.2. ASEAN
14.3.1. By Product Type
14.3.2. By Indication
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. Oceania Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. Australia
15.3.1.2. New Zealand
15.3.1. By Product Type
15.3.2. By Indication
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. Middle East and Africa Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. Turkey
16.3.1.3. South Africa
16.3.1. By Product Type
16.3.2. By Indication
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Key and Emerging Countries Traditional Chinese Medicine Market Analysis 2015-2019 and Forecast 2020-2030
17.1. U.S. Traditional Chinese Medicine Market Analysis
17.1.1. By Product Type
17.1.2. By Indication
17.2. Canada Traditional Chinese Medicine Market Analysis
17.2.1. By Product Type
17.2.2. By Indication
17.3. Brazil Traditional Chinese Medicine Market Analysis
17.3.1. By Product Type
17.3.2. By Indication
17.4. Mexico Traditional Chinese Medicine Market Analysis
17.4.1. By Product Type
17.4.2. By Indication
17.5. Argentina Traditional Chinese Medicine Market Analysis
17.5.1. By Product Type
17.5.2. By Indication
17.6. Germany Traditional Chinese Medicine Market Analysis
17.6.1. By Product Type
17.6.2. By Indication
17.7. U.K. Traditional Chinese Medicine Market Analysis
17.7.1. By Product Type
17.7.2. By Indication
17.8. France Traditional Chinese Medicine Market Analysis
17.8.1. By Product Type
17.8.2. By Indication
17.9. Italy Traditional Chinese Medicine Market Analysis
17.9.1. By Product Type
17.9.2. By Indication
17.10. Spain Traditional Chinese Medicine Market Analysis
17.10.1. By Product Type
17.10.2. By Indication
17.11. Benelux Traditional Chinese Medicine Market Analysis
17.11.1. By Product Type
17.11.2. By Indication
17.12. Russia Traditional Chinese Medicine Market Analysis
17.12.1. By Product Type
17.12.2. By Indication
17.13. China Traditional Chinese Medicine Market Analysis
17.13.1. By Product Type
17.13.2. By Indication
17.14. South Korea Traditional Chinese Medicine Market Analysis
17.14.1. By Product Type
17.14.2. By Indication
17.15. Japan Traditional Chinese Medicine Market Analysis
17.15.1. By Product Type
17.15.2. By Indication
17.16. India Traditional Chinese Medicine Market Analysis
17.16.1. By Product Type
17.16.2. By Indication
17.17. ASEAN Traditional Chinese Medicine Market Analysis
17.17.1. By Product Type
17.17.2. By Indication
17.18. Australia Traditional Chinese Medicine Market Analysis
17.18.1. By Product Type
17.18.2. By Indication
17.19. New Zealand Traditional Chinese Medicine Market Analysis
17.19.1. By Product Type
17.19.2. By Indication
17.20. GCC Countries Traditional Chinese Medicine Market Analysis
17.20.1. By Product Type
17.20.2. By Indication
17.21. Turkey Traditional Chinese Medicine Market Analysis
17.21.1. By Product Type
17.21.2. By Indication
17.22. South Africa Traditional Chinese Medicine Market Analysis
17.22.1. By Product Type
17.22.2. By Indication
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies (Traditional Chinese Medicines)
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Tongrentang
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Key Developments
19.3.1.5. Revenue Distribution, 2019
19.3.1.6. Revenue Growth
19.3.1.7. Strategic Overview
19.3.1.8. Qualitative & Quantitative Product Analysis
19.3.1.9. Product Pipeline Analysis
19.3.1.10. Analyst commentary
19.3.2. Zhongxin Pharmaceuticals
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Key Developments
19.3.2.5. Revenue Distribution, 2019
19.3.2.6. Revenue Growth
19.3.2.7. Strategic Overview
19.3.2.8. Qualitative & Quantitative Product Analysis
19.3.2.9. Product Pipeline Analysis
19.3.2.10. Analyst commentary
19.3.3. Tianjin Tasly Group
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Key Developments
19.3.3.5. Revenue Distribution, 2019
19.3.3.6. Revenue Growth
19.3.3.7. Strategic Overview
19.3.3.8. Qualitative & Quantitative Product Analysis
19.3.3.9. Product Pipeline Analysis
19.3.3.10. Analyst commentary
19.3.4. Yuannan Baiyao
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Key Developments
19.3.4.5. Revenue Distribution, 2019
19.3.4.6. Revenue Growth
19.3.4.7. Strategic Overview
19.3.4.8. Qualitative & Quantitative Product Analysis
19.3.4.9. Product Pipeline Analysis
19.3.4.10. Analyst commentary
19.3.5. Solstice Medicine Company, Inc.
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Key Developments
19.3.5.5. Revenue Distribution, 2019
19.3.5.6. Revenue Growth
19.3.5.7. Strategic Overview
19.3.5.8. Qualitative & Quantitative Product Analysis
19.3.5.9. Product Pipeline Analysis
19.3.5.10. Analyst commentary
19.3.6. Shanghai Sundise Traditional Chinese Medicine Co., Ltd
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Key Developments
19.3.6.5. Revenue Distribution, 2019
19.3.6.6. Revenue Growth
19.3.6.7. Strategic Overview
19.3.6.8. Qualitative & Quantitative Product Analysis
19.3.6.9. Product Pipeline Analysis
19.3.6.10. Analyst commentary
19.3.7. China Chinese Medicine Holding Co., Ltd.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Key Developments
19.3.7.5. Revenue Distribution, 2019
19.3.7.6. Revenue Growth
19.3.7.7. Strategic Overview
19.3.7.8. Qualitative & Quantitative Product Analysis
19.3.7.9. Product Pipeline Analysis
19.3.7.10. Analyst commentary
19.3.8. Hunan goldliloo pharmaceutical Co., Ltd
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Key Developments
19.3.8.5. Revenue Distribution, 2019
19.3.8.6. Revenue Growth
19.3.8.7. Strategic Overview
19.3.8.8. Qualitative & Quantitative Product Analysis
19.3.8.9. Product Pipeline Analysis
19.3.8.10. Analyst commentary
19.3.9. Wanbang Pharma Group Corp.
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Key Developments
19.3.9.5. Revenue Distribution, 2019
19.3.9.6. Revenue Growth
19.3.9.7. Strategic Overview
19.3.9.8. Qualitative & Quantitative Product Analysis
19.3.9.9. Product Pipeline Analysis
19.3.9.10. Analyst commentary
19.3.10. Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Key Developments
19.3.10.5. Revenue Distribution, 2019
19.3.10.6. Revenue Growth
19.3.10.7. Strategic Overview
19.3.10.8. Qualitative & Quantitative Product Analysis
19.3.10.9. Product Pipeline Analysis
19.3.10.10. Analyst commentary
19.3.11. Pfizer Inc.
19.3.11.1. Overview
19.3.11.2. Product Portfolio
19.3.11.3. Sales Footprint
19.3.11.4. Key Developments
19.3.11.5. Revenue Distribution, 2019
19.3.11.6. Revenue Growth
19.3.11.7. Strategic Overview
19.3.11.8. Qualitative & Quantitative Product Analysis
19.3.11.9. Product Pipeline Analysis
19.3.11.10. Analyst commentary
19.3.12. Eli Lilly and Company
19.3.12.1. Overview
19.3.12.2. Product Portfolio
19.3.12.3. Sales Footprint
19.3.12.4. Key Developments
19.3.12.5. Revenue Distribution, 2019
19.3.12.6. Revenue Growth
19.3.12.7. Strategic Overview
19.3.12.8. Qualitative & Quantitative Product Analysis
19.3.12.9. Product Pipeline Analysis
19.3.12.10. Analyst commentary
19.3.13. Novartis AG
19.3.13.1. Overview
19.3.13.2. Product Portfolio
19.3.13.3. Sales Footprint
19.3.13.4. Key Developments
19.3.13.5. Revenue Distribution, 2019
19.3.13.6. Revenue Growth
19.3.13.7. Strategic Overview
19.3.13.8. Qualitative & Quantitative Product Analysis
19.3.13.9. Product Pipeline Analysis
19.3.13.10. Analyst commentary
19.3.14. GlaxoSmithKline PLC
19.3.14.1. Overview
19.3.14.2. Product Portfolio
19.3.14.3. Sales Footprint
19.3.14.4. Key Developments
19.3.14.5. Revenue Distribution, 2019
19.3.14.6. Revenue Growth
19.3.14.7. Strategic Overview
19.3.14.8. Qualitative & Quantitative Product Analysis
19.3.14.9. Product Pipeline Analysis
19.3.14.10. Analyst commentary
19.3.15. Mallinckrodt Pharmaceuticals
19.3.15.1. Overview
19.3.15.2. Product Portfolio
19.3.15.3. Sales Footprint
19.3.15.4. Key Developments
19.3.15.5. Revenue Distribution, 2019
19.3.15.6. Revenue Growth
19.3.15.7. Strategic Overview
19.3.15.8. Qualitative & Quantitative Product Analysis
19.3.15.9. Product Pipeline Analysis
19.3.15.10. Analyst commentary
19.3.16. Hisamitsu Pharmaceutical Co., Inc.
19.3.16.1. Overview
19.3.16.2. Product Portfolio
19.3.16.3. Sales Footprint
19.3.16.4. Key Developments
19.3.16.5. Revenue Distribution, 2019
19.3.16.6. Revenue Growth
19.3.16.7. Strategic Overview
19.3.16.8. Qualitative & Quantitative Product Analysis
19.3.16.9. Product Pipeline Analysis
19.3.16.10. Analyst commentary
20. Assumptions and Acronyms Used
21. Research Methodology
Table 01: Global Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product TypeTable 02: Global Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
Table 03: Global Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
Table 04: North America Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 05: North America Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 06: North America Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
Table 07: Latin America Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 08: Latin America Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 09: Latin America Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
Table 10: Europe Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 11: Europe Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 12: Europe Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
Table 13: East Asia Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 14: East Asia Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 15: East Asia Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
Table 16: South Asia Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 17: South Asia Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 18: South Asia Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
Table 19: Oceania Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 20: Oceania Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 21: Oceania Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
Table 22: MEA Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 23: MEA Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 24: MEA Traditional Chinese Medicine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication